Spero Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -9,916.7% | -7,609.3% |
| FY2017 | — | -2,108.6% | -1,957.7% |
| FY2018 | — | -1,079.3% | -1,051.4% |
| FY2019 | — | -348.4% | -335.6% |
| FY2020 | — | -847.9% | -839.2% |
| FY2021 | — | -481.9% | -491.9% |
| FY2022 | — | -78.9% | -86.7% |
| FY2023 | — | 20.7% | 22.0% |
| FY2024 | — | -152.9% | -142.9% |
| FY2025 | — | 9.5% | 12.8% |